Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

The conference highlighted new diagnostic tools, the role of genetics in hair loss, and emerging treatments.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Hyperpigmentation is common in pregnancy and may not fully fade after birth; melasma, also frequent, can persist but has limited treatment options during pregnancy.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Understanding skin patterns can help us learn about skin diseases and their treatments.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

The document concludes that understanding hair biology is key to treating hair disorders, with gene therapy showing potential as a future treatment.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

Special supplements with collagen, vitamins, and minerals can help treat hair loss.

The protein STAT3 slows down cell growth by blocking the FST gene, which affects hair development in sheep.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Polymeric nanoparticles show promise for treating skin diseases.

TGF-β signaling is crucial for stem cell maintenance, differentiation, and has implications for cancer treatment.

Targeting the Smoothened receptor shows promise for treating certain cancers.

New therapies are being developed that target integrin pathways to treat various diseases.

Injecting lentiviral vectors into early gestation mice effectively targets skin stem cells for potential gene therapy.

Targeting cellular senescence may improve skin aging and disorders.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

GFRα2 is essential for controlling neuron size but not for target innervation in certain sensory neurons.

MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.

Skin's epithelial stem cells are crucial for repair and maintenance, and understanding them could improve treatments for skin problems.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Asthma may increase the risk of alopecia areata.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Copper may protect against alopecia areata, while certain inflammatory markers increase risk.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Autoimmune skin disorders are caused by genetic and environmental factors and are treated with various medications and preventative strategies.